Global Oral Contraceptive Market Insights and Forecast to 2031

Report ID: 1379693 | Published Date: Sep 2024 | No. of Page: 97 | Base Year: 2023 | Rating: 4.1 | Webstory: Check our Web story
1 Study Coverage
    1.1 Oral Contraceptive Product Introduction
    1.2 Market by Type
        1.2.1 Global Oral Contraceptive Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Combination
        1.2.3 Progestin Only
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Oral Contraceptive Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Male
        1.3.3 Female
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Oral Contraceptive Sales Estimates and Forecasts 2017-2028
    2.2 Global Oral Contraceptive Revenue Estimates and Forecasts 2017-2028
    2.3 Global Oral Contraceptive Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Oral Contraceptive Sales by Region
        2.4.1 Global Oral Contraceptive Sales by Region (2017-2022)
        2.4.2 Global Sales Oral Contraceptive by Region (2023-2028)
    2.5 Global Oral Contraceptive Revenue by Region
        2.5.1 Global Oral Contraceptive Revenue by Region (2017-2022)
        2.5.2 Global Oral Contraceptive Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Oral Contraceptive Sales by Manufacturers
        3.1.1 Global Top Oral Contraceptive Manufacturers by Sales (2017-2022)
        3.1.2 Global Oral Contraceptive Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Oral Contraceptive in 2021
    3.2 Global Oral Contraceptive Revenue by Manufacturers
        3.2.1 Global Oral Contraceptive Revenue by Manufacturers (2017-2022)
        3.2.2 Global Oral Contraceptive Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Oral Contraceptive Revenue in 2021
    3.3 Global Oral Contraceptive Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Oral Contraceptive Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Oral Contraceptive Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Oral Contraceptive Sales by Type
        4.1.1 Global Oral Contraceptive Historical Sales by Type (2017-2022)
        4.1.2 Global Oral Contraceptive Forecasted Sales by Type (2023-2028)
        4.1.3 Global Oral Contraceptive Sales Market Share by Type (2017-2028)
    4.2 Global Oral Contraceptive Revenue by Type
        4.2.1 Global Oral Contraceptive Historical Revenue by Type (2017-2022)
        4.2.2 Global Oral Contraceptive Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Oral Contraceptive Revenue Market Share by Type (2017-2028)
    4.3 Global Oral Contraceptive Price by Type
        4.3.1 Global Oral Contraceptive Price by Type (2017-2022)
        4.3.2 Global Oral Contraceptive Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Oral Contraceptive Sales by Application
        5.1.1 Global Oral Contraceptive Historical Sales by Application (2017-2022)
        5.1.2 Global Oral Contraceptive Forecasted Sales by Application (2023-2028)
        5.1.3 Global Oral Contraceptive Sales Market Share by Application (2017-2028)
    5.2 Global Oral Contraceptive Revenue by Application
        5.2.1 Global Oral Contraceptive Historical Revenue by Application (2017-2022)
        5.2.2 Global Oral Contraceptive Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Oral Contraceptive Revenue Market Share by Application (2017-2028)
    5.3 Global Oral Contraceptive Price by Application
        5.3.1 Global Oral Contraceptive Price by Application (2017-2022)
        5.3.2 Global Oral Contraceptive Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Oral Contraceptive Market Size by Type
        6.1.1 North America Oral Contraceptive Sales by Type (2017-2028)
        6.1.2 North America Oral Contraceptive Revenue by Type (2017-2028)
    6.2 North America Oral Contraceptive Market Size by Application
        6.2.1 North America Oral Contraceptive Sales by Application (2017-2028)
        6.2.2 North America Oral Contraceptive Revenue by Application (2017-2028)
    6.3 North America Oral Contraceptive Market Size by Country
        6.3.1 North America Oral Contraceptive Sales by Country (2017-2028)
        6.3.2 North America Oral Contraceptive Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Oral Contraceptive Market Size by Type
        7.1.1 Europe Oral Contraceptive Sales by Type (2017-2028)
        7.1.2 Europe Oral Contraceptive Revenue by Type (2017-2028)
    7.2 Europe Oral Contraceptive Market Size by Application
        7.2.1 Europe Oral Contraceptive Sales by Application (2017-2028)
        7.2.2 Europe Oral Contraceptive Revenue by Application (2017-2028)
    7.3 Europe Oral Contraceptive Market Size by Country
        7.3.1 Europe Oral Contraceptive Sales by Country (2017-2028)
        7.3.2 Europe Oral Contraceptive Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Oral Contraceptive Market Size by Type
        8.1.1 Asia Pacific Oral Contraceptive Sales by Type (2017-2028)
        8.1.2 Asia Pacific Oral Contraceptive Revenue by Type (2017-2028)
    8.2 Asia Pacific Oral Contraceptive Market Size by Application
        8.2.1 Asia Pacific Oral Contraceptive Sales by Application (2017-2028)
        8.2.2 Asia Pacific Oral Contraceptive Revenue by Application (2017-2028)
    8.3 Asia Pacific Oral Contraceptive Market Size by Region
        8.3.1 Asia Pacific Oral Contraceptive Sales by Region (2017-2028)
        8.3.2 Asia Pacific Oral Contraceptive Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Oral Contraceptive Market Size by Type
        9.1.1 Latin America Oral Contraceptive Sales by Type (2017-2028)
        9.1.2 Latin America Oral Contraceptive Revenue by Type (2017-2028)
    9.2 Latin America Oral Contraceptive Market Size by Application
        9.2.1 Latin America Oral Contraceptive Sales by Application (2017-2028)
        9.2.2 Latin America Oral Contraceptive Revenue by Application (2017-2028)
    9.3 Latin America Oral Contraceptive Market Size by Country
        9.3.1 Latin America Oral Contraceptive Sales by Country (2017-2028)
        9.3.2 Latin America Oral Contraceptive Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Oral Contraceptive Market Size by Type
        10.1.1 Middle East and Africa Oral Contraceptive Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Oral Contraceptive Revenue by Type (2017-2028)
    10.2 Middle East and Africa Oral Contraceptive Market Size by Application
        10.2.1 Middle East and Africa Oral Contraceptive Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Oral Contraceptive Revenue by Application (2017-2028)
    10.3 Middle East and Africa Oral Contraceptive Market Size by Country
        10.3.1 Middle East and Africa Oral Contraceptive Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Oral Contraceptive Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Pfizer, Inc.
        11.1.1 Pfizer, Inc. Corporation Information
        11.1.2 Pfizer, Inc. Overview
        11.1.3 Pfizer, Inc. Oral Contraceptive Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Pfizer, Inc. Oral Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Pfizer, Inc. Recent Developments
    11.2 Bayer AG
        11.2.1 Bayer AG Corporation Information
        11.2.2 Bayer AG Overview
        11.2.3 Bayer AG Oral Contraceptive Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Bayer AG Oral Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Bayer AG Recent Developments
    11.3 Merck & Co., Inc.
        11.3.1 Merck & Co., Inc. Corporation Information
        11.3.2 Merck & Co., Inc. Overview
        11.3.3 Merck & Co., Inc. Oral Contraceptive Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Merck & Co., Inc. Oral Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Merck & Co., Inc. Recent Developments
    11.4 Janssen Global Services, LLC
        11.4.1 Janssen Global Services, LLC Corporation Information
        11.4.2 Janssen Global Services, LLC Overview
        11.4.3 Janssen Global Services, LLC Oral Contraceptive Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Janssen Global Services, LLC Oral Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Janssen Global Services, LLC Recent Developments
    11.5 Mankind Pharma Ltd.
        11.5.1 Mankind Pharma Ltd. Corporation Information
        11.5.2 Mankind Pharma Ltd. Overview
        11.5.3 Mankind Pharma Ltd. Oral Contraceptive Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Mankind Pharma Ltd. Oral Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Mankind Pharma Ltd. Recent Developments
    11.6 Teva Pharmaceutical Industries Ltd
        11.6.1 Teva Pharmaceutical Industries Ltd Corporation Information
        11.6.2 Teva Pharmaceutical Industries Ltd Overview
        11.6.3 Teva Pharmaceutical Industries Ltd Oral Contraceptive Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Teva Pharmaceutical Industries Ltd Oral Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Teva Pharmaceutical Industries Ltd Recent Developments
    11.7 Allergan, plc (Actavis)
        11.7.1 Allergan, plc (Actavis) Corporation Information
        11.7.2 Allergan, plc (Actavis) Overview
        11.7.3 Allergan, plc (Actavis) Oral Contraceptive Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Allergan, plc (Actavis) Oral Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Allergan, plc (Actavis) Recent Developments
    11.8 Piramal Enterprises Ltd.
        11.8.1 Piramal Enterprises Ltd. Corporation Information
        11.8.2 Piramal Enterprises Ltd. Overview
        11.8.3 Piramal Enterprises Ltd. Oral Contraceptive Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Piramal Enterprises Ltd. Oral Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Piramal Enterprises Ltd. Recent Developments
    11.9 Beijing Zizhu Pharm
        11.9.1 Beijing Zizhu Pharm Corporation Information
        11.9.2 Beijing Zizhu Pharm Overview
        11.9.3 Beijing Zizhu Pharm Oral Contraceptive Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Beijing Zizhu Pharm Oral Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Beijing Zizhu Pharm Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Oral Contraceptive Industry Chain Analysis
    12.2 Oral Contraceptive Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Oral Contraceptive Production Mode & Process
    12.4 Oral Contraceptive Sales and Marketing
        12.4.1 Oral Contraceptive Sales Channels
        12.4.2 Oral Contraceptive Distributors
    12.5 Oral Contraceptive Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Oral Contraceptive Industry Trends
    13.2 Oral Contraceptive Market Drivers
    13.3 Oral Contraceptive Market Challenges
    13.4 Oral Contraceptive Market Restraints
14 Key Findings in The Global Oral Contraceptive Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
List of Tables
    Table 1. Global Oral Contraceptive Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Combination
    Table 3. Major Manufacturers of Progestin Only
    Table 4. Major Manufacturers of Others
    Table 5. Global Oral Contraceptive Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Oral Contraceptive Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Oral Contraceptive Sales by Region (2017-2022) & (K Units)
    Table 8. Global Oral Contraceptive Sales Market Share by Region (2017-2022)
    Table 9. Global Oral Contraceptive Sales by Region (2023-2028) & (K Units)
    Table 10. Global Oral Contraceptive Sales Market Share by Region (2023-2028)
    Table 11. Global Oral Contraceptive Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Oral Contraceptive Revenue Market Share by Region (2017-2022)
    Table 13. Global Oral Contraceptive Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global Oral Contraceptive Revenue Market Share by Region (2023-2028)
    Table 15. Global Oral Contraceptive Sales by Manufacturers (2017-2022) & (K Units)
    Table 16. Global Oral Contraceptive Sales Share by Manufacturers (2017-2022)
    Table 17. Global Oral Contraceptive Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global Oral Contraceptive Revenue Share by Manufacturers (2017-2022)
    Table 19. Oral Contraceptive Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 20. Global Oral Contraceptive Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Oral Contraceptive by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Contraceptive as of 2021)
    Table 22. Oral Contraceptive Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Oral Contraceptive Product Offered
    Table 24. Date of Manufacturers Enter into Oral Contraceptive Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Oral Contraceptive Sales by Type (2017-2022) & (K Units)
    Table 27. Global Oral Contraceptive Sales by Type (2023-2028) & (K Units)
    Table 28. Global Oral Contraceptive Sales Share by Type (2017-2022)
    Table 29. Global Oral Contraceptive Sales Share by Type (2023-2028)
    Table 30. Global Oral Contraceptive Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global Oral Contraceptive Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global Oral Contraceptive Revenue Share by Type (2017-2022)
    Table 33. Global Oral Contraceptive Revenue Share by Type (2023-2028)
    Table 34. Oral Contraceptive Price by Type (2017-2022) & (USD/Unit)
    Table 35. Global Oral Contraceptive Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 36. Global Oral Contraceptive Sales by Application (2017-2022) & (K Units)
    Table 37. Global Oral Contraceptive Sales by Application (2023-2028) & (K Units)
    Table 38. Global Oral Contraceptive Sales Share by Application (2017-2022)
    Table 39. Global Oral Contraceptive Sales Share by Application (2023-2028)
    Table 40. Global Oral Contraceptive Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global Oral Contraceptive Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global Oral Contraceptive Revenue Share by Application (2017-2022)
    Table 43. Global Oral Contraceptive Revenue Share by Application (2023-2028)
    Table 44. Oral Contraceptive Price by Application (2017-2022) & (USD/Unit)
    Table 45. Global Oral Contraceptive Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 46. North America Oral Contraceptive Sales by Type (2017-2022) & (K Units)
    Table 47. North America Oral Contraceptive Sales by Type (2023-2028) & (K Units)
    Table 48. North America Oral Contraceptive Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America Oral Contraceptive Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America Oral Contraceptive Sales by Application (2017-2022) & (K Units)
    Table 51. North America Oral Contraceptive Sales by Application (2023-2028) & (K Units)
    Table 52. North America Oral Contraceptive Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America Oral Contraceptive Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America Oral Contraceptive Sales by Country (2017-2022) & (K Units)
    Table 55. North America Oral Contraceptive Sales by Country (2023-2028) & (K Units)
    Table 56. North America Oral Contraceptive Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America Oral Contraceptive Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe Oral Contraceptive Sales by Type (2017-2022) & (K Units)
    Table 59. Europe Oral Contraceptive Sales by Type (2023-2028) & (K Units)
    Table 60. Europe Oral Contraceptive Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe Oral Contraceptive Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe Oral Contraceptive Sales by Application (2017-2022) & (K Units)
    Table 63. Europe Oral Contraceptive Sales by Application (2023-2028) & (K Units)
    Table 64. Europe Oral Contraceptive Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe Oral Contraceptive Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe Oral Contraceptive Sales by Country (2017-2022) & (K Units)
    Table 67. Europe Oral Contraceptive Sales by Country (2023-2028) & (K Units)
    Table 68. Europe Oral Contraceptive Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe Oral Contraceptive Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific Oral Contraceptive Sales by Type (2017-2022) & (K Units)
    Table 71. Asia Pacific Oral Contraceptive Sales by Type (2023-2028) & (K Units)
    Table 72. Asia Pacific Oral Contraceptive Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific Oral Contraceptive Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Oral Contraceptive Sales by Application (2017-2022) & (K Units)
    Table 75. Asia Pacific Oral Contraceptive Sales by Application (2023-2028) & (K Units)
    Table 76. Asia Pacific Oral Contraceptive Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Oral Contraceptive Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Oral Contraceptive Sales by Region (2017-2022) & (K Units)
    Table 79. Asia Pacific Oral Contraceptive Sales by Region (2023-2028) & (K Units)
    Table 80. Asia Pacific Oral Contraceptive Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Oral Contraceptive Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America Oral Contraceptive Sales by Type (2017-2022) & (K Units)
    Table 83. Latin America Oral Contraceptive Sales by Type (2023-2028) & (K Units)
    Table 84. Latin America Oral Contraceptive Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America Oral Contraceptive Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America Oral Contraceptive Sales by Application (2017-2022) & (K Units)
    Table 87. Latin America Oral Contraceptive Sales by Application (2023-2028) & (K Units)
    Table 88. Latin America Oral Contraceptive Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America Oral Contraceptive Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America Oral Contraceptive Sales by Country (2017-2022) & (K Units)
    Table 91. Latin America Oral Contraceptive Sales by Country (2023-2028) & (K Units)
    Table 92. Latin America Oral Contraceptive Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America Oral Contraceptive Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa Oral Contraceptive Sales by Type (2017-2022) & (K Units)
    Table 95. Middle East and Africa Oral Contraceptive Sales by Type (2023-2028) & (K Units)
    Table 96. Middle East and Africa Oral Contraceptive Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa Oral Contraceptive Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Oral Contraceptive Sales by Application (2017-2022) & (K Units)
    Table 99. Middle East and Africa Oral Contraceptive Sales by Application (2023-2028) & (K Units)
    Table 100. Middle East and Africa Oral Contraceptive Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Oral Contraceptive Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Oral Contraceptive Sales by Country (2017-2022) & (K Units)
    Table 103. Middle East and Africa Oral Contraceptive Sales by Country (2023-2028) & (K Units)
    Table 104. Middle East and Africa Oral Contraceptive Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Oral Contraceptive Revenue by Country (2023-2028) & (US$ Million)
    Table 106. Pfizer, Inc. Corporation Information
    Table 107. Pfizer, Inc. Description and Major Businesses
    Table 108. Pfizer, Inc. Oral Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 109. Pfizer, Inc. Oral Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. Pfizer, Inc. Recent Developments
    Table 111. Bayer AG Corporation Information
    Table 112. Bayer AG Description and Major Businesses
    Table 113. Bayer AG Oral Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 114. Bayer AG Oral Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. Bayer AG Recent Developments
    Table 116. Merck & Co., Inc. Corporation Information
    Table 117. Merck & Co., Inc. Description and Major Businesses
    Table 118. Merck & Co., Inc. Oral Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 119. Merck & Co., Inc. Oral Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. Merck & Co., Inc. Recent Developments
    Table 121. Janssen Global Services, LLC Corporation Information
    Table 122. Janssen Global Services, LLC Description and Major Businesses
    Table 123. Janssen Global Services, LLC Oral Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 124. Janssen Global Services, LLC Oral Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. Janssen Global Services, LLC Recent Developments
    Table 126. Mankind Pharma Ltd. Corporation Information
    Table 127. Mankind Pharma Ltd. Description and Major Businesses
    Table 128. Mankind Pharma Ltd. Oral Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 129. Mankind Pharma Ltd. Oral Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. Mankind Pharma Ltd. Recent Developments
    Table 131. Teva Pharmaceutical Industries Ltd Corporation Information
    Table 132. Teva Pharmaceutical Industries Ltd Description and Major Businesses
    Table 133. Teva Pharmaceutical Industries Ltd Oral Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 134. Teva Pharmaceutical Industries Ltd Oral Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. Teva Pharmaceutical Industries Ltd Recent Developments
    Table 136. Allergan, plc (Actavis) Corporation Information
    Table 137. Allergan, plc (Actavis) Description and Major Businesses
    Table 138. Allergan, plc (Actavis) Oral Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 139. Allergan, plc (Actavis) Oral Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
    Table 140. Allergan, plc (Actavis) Recent Developments
    Table 141. Piramal Enterprises Ltd. Corporation Information
    Table 142. Piramal Enterprises Ltd. Description and Major Businesses
    Table 143. Piramal Enterprises Ltd. Oral Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 144. Piramal Enterprises Ltd. Oral Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
    Table 145. Piramal Enterprises Ltd. Recent Developments
    Table 146. Beijing Zizhu Pharm Corporation Information
    Table 147. Beijing Zizhu Pharm Description and Major Businesses
    Table 148. Beijing Zizhu Pharm Oral Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 149. Beijing Zizhu Pharm Oral Contraceptive Product Model Numbers, Pictures, Descriptions and Specifications
    Table 150. Beijing Zizhu Pharm Recent Developments
    Table 151. Key Raw Materials Lists
    Table 152. Raw Materials Key Suppliers Lists
    Table 153. Oral Contraceptive Distributors List
    Table 154. Oral Contraceptive Customers List
    Table 155. Oral Contraceptive Market Trends
    Table 156. Oral Contraceptive Market Drivers
    Table 157. Oral Contraceptive Market Challenges
    Table 158. Oral Contraceptive Market Restraints
    Table 159. Research Programs/Design for This Report
    Table 160. Key Data Information from Secondary Sources
    Table 161. Key Data Information from Primary Sources
List of Figures
    Figure 1. Oral Contraceptive Product Picture
    Figure 3. Global Oral Contraceptive Market Share by Type in 2021 & 2028
    Figure 3. Combination Product Picture
    Figure 4. Progestin Only Product Picture
    Figure 5. Others Product Picture
    Figure 6. Global Oral Contraceptive Market Share by Application in 2021 & 2028
    Figure 7. Male
    Figure 8. Female
    Figure 9. Oral Contraceptive Report Years Considered
    Figure 10. Global Oral Contraceptive Sales 2017-2028 (K Units)
    Figure 11. Global Oral Contraceptive Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Oral Contraceptive Revenue 2017-2028 (US$ Million)
    Figure 13. Global Oral Contraceptive Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 14. Global Oral Contraceptive Sales Market Share by Region (2017-2022)
    Figure 15. Global Oral Contraceptive Sales Market Share by Region (2023-2028)
    Figure 16. North America Oral Contraceptive Sales YoY (2017-2028) & (K Units)
    Figure 17. North America Oral Contraceptive Revenue YoY (2017-2028) & (US$ Million)
    Figure 18. Europe Oral Contraceptive Sales YoY (2017-2028) & (K Units)
    Figure 19. Europe Oral Contraceptive Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Asia-Pacific Oral Contraceptive Sales YoY (2017-2028) & (K Units)
    Figure 21. Asia-Pacific Oral Contraceptive Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Latin America Oral Contraceptive Sales YoY (2017-2028) & (K Units)
    Figure 23. Latin America Oral Contraceptive Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Middle East & Africa Oral Contraceptive Sales YoY (2017-2028) & (K Units)
    Figure 25. Middle East & Africa Oral Contraceptive Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. The Oral Contraceptive Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 27. The Top 5 and 10 Largest Manufacturers of Oral Contraceptive in the World: Market Share by Oral Contraceptive Revenue in 2021
    Figure 28. Global Oral Contraceptive Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 29. Global Oral Contraceptive Sales Market Share by Type (2017-2028)
    Figure 30. Global Oral Contraceptive Revenue Market Share by Type (2017-2028)
    Figure 31. Global Oral Contraceptive Sales Market Share by Application (2017-2028)
    Figure 32. Global Oral Contraceptive Revenue Market Share by Application (2017-2028)
    Figure 33. North America Oral Contraceptive Sales Market Share by Type (2017-2028)
    Figure 34. North America Oral Contraceptive Revenue Market Share by Type (2017-2028)
    Figure 35. North America Oral Contraceptive Sales Market Share by Application (2017-2028)
    Figure 36. North America Oral Contraceptive Revenue Market Share by Application (2017-2028)
    Figure 37. North America Oral Contraceptive Sales Share by Country (2017-2028)
    Figure 38. North America Oral Contraceptive Revenue Share by Country (2017-2028)
    Figure 39. U.S. Oral Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 40. Canada Oral Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 41. Europe Oral Contraceptive Sales Market Share by Type (2017-2028)
    Figure 42. Europe Oral Contraceptive Revenue Market Share by Type (2017-2028)
    Figure 43. Europe Oral Contraceptive Sales Market Share by Application (2017-2028)
    Figure 44. Europe Oral Contraceptive Revenue Market Share by Application (2017-2028)
    Figure 45. Europe Oral Contraceptive Sales Share by Country (2017-2028)
    Figure 46. Europe Oral Contraceptive Revenue Share by Country (2017-2028)
    Figure 47. Germany Oral Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 48. France Oral Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 49. U.K. Oral Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 50. Italy Oral Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 51. Russia Oral Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 52. Asia Pacific Oral Contraceptive Sales Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Oral Contraceptive Revenue Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Oral Contraceptive Sales Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Oral Contraceptive Revenue Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Oral Contraceptive Sales Share by Region (2017-2028)
    Figure 57. Asia Pacific Oral Contraceptive Revenue Share by Region (2017-2028)
    Figure 58. China Oral Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 59. Japan Oral Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 60. South Korea Oral Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 61. India Oral Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 62. Australia Oral Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 63. Taiwan Oral Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 64. Indonesia Oral Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 65. Thailand Oral Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 66. Malaysia Oral Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 67. Philippines Oral Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 68. Latin America Oral Contraceptive Sales Market Share by Type (2017-2028)
    Figure 69. Latin America Oral Contraceptive Revenue Market Share by Type (2017-2028)
    Figure 70. Latin America Oral Contraceptive Sales Market Share by Application (2017-2028)
    Figure 71. Latin America Oral Contraceptive Revenue Market Share by Application (2017-2028)
    Figure 72. Latin America Oral Contraceptive Sales Share by Country (2017-2028)
    Figure 73. Latin America Oral Contraceptive Revenue Share by Country (2017-2028)
    Figure 74. Mexico Oral Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 75. Brazil Oral Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 76. Argentina Oral Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 77. Middle East and Africa Oral Contraceptive Sales Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Oral Contraceptive Revenue Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Oral Contraceptive Sales Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Oral Contraceptive Revenue Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Oral Contraceptive Sales Share by Country (2017-2028)
    Figure 82. Middle East and Africa Oral Contraceptive Revenue Share by Country (2017-2028)
    Figure 83. Turkey Oral Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 84. Saudi Arabia Oral Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 85. UAE Oral Contraceptive Revenue (2017-2028) & (US$ Million)
    Figure 86. Oral Contraceptive Value Chain
    Figure 87. Oral Contraceptive Production Process
    Figure 88. Channels of Distribution
    Figure 89. Distributors Profiles
    Figure 90. Bottom-up and Top-down Approaches for This Report
    Figure 91. Data Triangulation
    Figure 92. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer, Inc.
Bayer AG
Merck & Co., Inc.
Janssen Global Services, LLC
Mankind Pharma Ltd.
Teva Pharmaceutical Industries Ltd
Allergan, plc (Actavis)
Piramal Enterprises Ltd.
Beijing Zizhu Pharm
Frequently Asked Questions
Oral Contraceptive report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Oral Contraceptive report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Oral Contraceptive report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Printer Toner

Printer Toner market is segmented by Type and by Application. Players, stakeholders, and other pa ... Read More

Printer Ink

Printer Ink market is segmented by Type and by Application. Players, stakeholders, and other part ... Read More

Intestinal Stents

Intestinal Stents market is segmented by Type and by Application. Players, stakeholders, and othe ... Read More

Pumpjack

Pumpjack market is segmented by Type and by Application. Players, stakeholders, and other partici ... Read More